Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner ( http://Dictionary.Reference.com/browse/blood%20thinner?s=ts ) Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, including the makers of Xarelto, possess a duty to make sure that their drugs are reasonably secure for use - and failure to do so may possibly be grounds for compensation. Our lawyers are working tough to have those hurt by the drug the compensation they are entitled to.
Even though bleeding can xarelto be split ( https://tortlawyers.s3.amazonaws.com/categories/Xarelto-Lawsuit-Attorneys-in-Wyoming/Xarelto-Medication-Interactions-Cheyenne-WY-82010.html ) be a typical complication connected with anticoagulants, it has been alleged that Xarelto is more unsafe than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This indicates that, within the occasion of an emergency, sufferers might be at danger for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or possibly a loved one suffered a critical bleeding occasion following taking Xarelto, you might have legal recourse. For a lot more info, contact us today to possess your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in instances of death, funeral expenses. In addition, they may be in search of punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for much more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled ( http://En.search.wordpress.com/?q=scheduled ) for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.